We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Alternative Therapy for Ear Infections

By HospiMedica staff writers
Posted on 05 Sep 2000
A panel of pediatricians and otolaryngologists from the American Academy of Pediatrics has determined that a topical antibiotic is an acceptable alternative to oral antibiotics for treating children with ear tubes who develop ear infections. More...
The findings of the panel, which met in Boston (MA, USA), are to be published in a future issue of the Pediatric Infectious Disease Journal.

The traditional treatment for children with middle ear infections is oral antibiotics. However, the incidence of antibiotic resistance is increasing. As the use of oral antibiotics grows, so does the incidence of resistance. Doctors place ear tubes in many children who have recurring infections to deter infection, but some children still become infected. Middle ear infections and drainage in these children can be treated with Floxin (ofloxacin otic solution, 0.3%), atopical antibiotic, said the panel.

"A topical antibiotic can be the first-line treatment of choice when treating ear drainage and infected ear tubes, if there is no underlying systemic infection,” stated panelist Seth Pransky, M.D., director, pediatric otolaryngology at Children's Hospital, San Diego, CA, USA.

Floxin has been cleared by the U.S. Food and Drug Administration (FDA) for otitis externa in patients aged one year or older (due to Pseudomonas aeruginosa and Staphylococcus aureus), acute otitis media in pediatric patients aged one year or older with tympanostomy tubes (due to P aeruginosa, S aureus, Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae), and chronic suppurative otitis media in patients 12 years or older with perforated tympanic membranes (due to P aeruginosa, S aureus, or Proteus mirabilis). Floxin is the product of Daiichi Pharmaceutical Corp. (Tokyo, Japan).

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.